Navigation Links
Mutant Genes in High-Risk Childhood Leukemias Identified
Date:5/19/2009

arroll (New York University Cancer Institute); and Gregory H. Reaman (The George Washington University).

This research was supported in part by a supplement to the Children's Oncology Group Chair's award; a National Cancer Institute Strategic Partnering to Evaluate Cancer Signatures Program award; the National Institutes of Health/National Institute of General Medical Sciences Pharmacogenetics Research Network and Database; National Institutes of Health Cancer Center Core Grants; the Children's Oncology Group and Statistical Center; the Leukemia and Lymphoma Society Specialized Center of Research grant supporting University of New Mexico Cancer Center; CureSearch; St. Baldrick's Foundation; a National Health and Medical Research Council (Australia) CJ Martin Traveling Fellowship; and ALSAC.

St. Jude Children's Research Hospital

St. Jude Children's Research Hospital is internationally recognized for its pioneering work in finding cures and saving children with cancer and other catastrophic diseases. Founded by late entertainer Danny Thomas and based in Memphis, Tenn., St. Jude freely shares its discoveries with scientific and medical communities around the world. No family ever pays for treatments not covered by insurance, and families without insurance are never asked to pay. St. Jude is financially supported by ALSAC, its fundraising organization. For more information, please visit www.stjude.org.

The Children's Oncology Group/CureSearch

Children's Oncology Group (COG), the world's largest cooperative pediatric cancer research organization, which includes every recognized pediatric cancer program in North America, comprises a network of more than 5,000 physician, nurse, and other clinical and laboratory investigators whose collaboration in clinical and translational researc
'/>"/>

SOURCE St. Jude Children's Research Hospital
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. National Jewish, Brigham and Womens Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
2. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
3. Intradigm Study Shows Ability of siRNAs Systemically Delivered With TargeTran(TM) System to Suppress Tumor-Induced Angiogenesis in Mice
4. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
5. Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus
6. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
7. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
8. deCODE Launches a DNA-Based Test for Assessing Risk of Prostate Cancer on the Back of the Discovery of New Prostate Cancer Genes
9. Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
10. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
11. Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... PARK CITY, Utah , Sept. 17, 2014 ... into an exclusive global licensing and collaboration agreement ... develop and commercialize NuView,s investigative genomic-based diagnostic biomarker ... The agreement also includes all other future diagnostic-imaging ... compound for in-vivo therapeutic delivery and in-vitro urine ...
(Date:9/17/2014)... Sept. 17, 2014 Cardiac Dimensions ® ... from the TITAN II clinical trial of its ... sustained improvements in mitral regurgitation, functional improvement, quality ... safety and efficacy data, which was consistent with ... 13 at the 26 th annual Transcatheter ...
(Date:9/17/2014)... MILL VALLEY, Calif. , Sept. ... today announced a partnership in the fight against ... the Sarcoma Alliance Suzanne Renee Leider Memorial Assistance ... financial assistance to reimburse sarcoma patients for expenses ... a sarcoma specialist. Scientific literature reinforces the importance ...
Breaking Medicine Technology:NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 2NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 3NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 4NuView Life Sciences Enters Global Licensing Agreement With Otsuka Pharmaceutical 5Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System 2Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System 3Champions Oncology Partners with Sarcoma Alliance to Bring Personalized Treatment Options to Sarcoma Patients 2Champions Oncology Partners with Sarcoma Alliance to Bring Personalized Treatment Options to Sarcoma Patients 3
... , BOSTON, Nov. 23 AMICAS, Inc. ... management solutions, today announced that it will highlight its enterprise ... America (RSNA) annual meeting from November 29 to December 4 ... in booth #7124. , (Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ) ...
... , MINNEAPOLIS, Nov. 23 BridgePoint Medical announced ... for its coronary and peripheral Chronic Total Occlusion (CTO) ... and the Stingray® CTO Re-Entry System. The BridgePoint ... designed to navigate highly diseased arteries in preparation for ...
Cached Medicine Technology:AMICAS' Enterprise Imaging Solutions Highlighted at RSNA 2009 2AMICAS' Enterprise Imaging Solutions Highlighted at RSNA 2009 3BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries 2BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries 3
(Date:9/17/2014)... 2014 Promising new research published in ... light on the potential ability of ketones to support ... The study shows that brain hypometabolism ... by impaired glucose uptake and/or utilization, and results suggest ... , The study, by the Research Center on Aging ...
(Date:9/17/2014)... September 16, 2014) A study led by ... the chemotherapy dose threshold below which male childhood ... production. The study appears in September 17 edition ... By clarifying which patients are at highest risk ... the findings to eventually increase use of pre-treatment ...
(Date:9/17/2014)... wine leads to an explosion of flavours in your mouth. ... that can mimic what happens in your mouth when you ... of dryness in the wine. , When wine growers turn ... of processes to bring out the desired flavour in the ... part of the taste is known in wine terminology as ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 A  recent ... of a 24-year-old man named Advait Thakur who had ... caused by degenerative disc disease. This disease led to ... his nerve roots and causing severe pain. Leading spine ... and how it can lead to such severe pain, ...
(Date:9/17/2014)... NetDimensions (AIM: NETD; OTCQX: NETDY), a global ... the opening of the 2014 Next Steps user conference ... very excited to meet up in Chicago again this ... Steps from our clients and partners, which shows how ... look forward to some very engaging and fun days ...
Breaking Medicine News(10 mins):Health News:Journal of Alzheimer's Disease Publishes New Study Suggesting Ketones have Potential to Compensate for Brain Energy Deficit 2Health News:Journal of Alzheimer's Disease Publishes New Study Suggesting Ketones have Potential to Compensate for Brain Energy Deficit 3Health News:Improved risk identification will aid fertility preservation in young male cancer patients 2Health News:Improved risk identification will aid fertility preservation in young male cancer patients 3Health News:Nanoscience makes your wine better 2Health News:Nanoscience makes your wine better 3Health News:24-Year-Old Back in College After Degenerative Disc Disease Kept Him Out 2Health News:24-Year-Old Back in College After Degenerative Disc Disease Kept Him Out 3Health News:NetDimensions Next Steps User Conference in North America Opens Today with Record Attendance 2Health News:NetDimensions Next Steps User Conference in North America Opens Today with Record Attendance 3
... By Steven Reinberg HealthDay Reporter , THURSDAY, Sept. ... phone use and texting soared in the space of three ... Texting alone caused more than 16,000 deaths in car accidents ... involving cell phones and texting while driving rose 28 percent ...
... S. Bloomberg Faculty of Nursing professor, Dr. Diane Doran, ... will help protect the safety of over 900,000 Canadians ... day. The Canadian Patient Safety Institute and its ... research competition drawing some of Canada,s leading healthcare researchers. ...
... Reporter , THURSDAY, Sept. 23 (HealthDay News) -- It was ... dream. He,d just been plucked from his life as ... the National Basketball Association,s Dallas Mavericks, summer training camp after ... But a small on-court collision with another player led to ...
... to boost research on women,s health over the last two ... among women due to cardiovascular disease, breast cancer, and cervical ... The effort has yielded less but still significant progress ... women, added the committee that wrote the report. ...
... pathology at the University of California, San Diego School ... the Moores UCSD Cancer Center, has been named the ... bestowed by the Metastasis Research Society, an international, non-profit ... was honored at a recent joint meeting of the ...
... and Tallinn, Estonia (September 23, 2010) At an international ... Global TB Vaccine Foundation announced it will initiate a clinical ... led by researchers at Saint Louis University in St. Louis, ... Global Forum on TB Vaccine Development. Building on ...
Cached Medicine News:Health News:Texting Taking a Deadly Toll on Roads 2Health News:Texting Taking a Deadly Toll on Roads 3Health News:$1 million awarded to Bloomberg Faculty of Nursing-led research team 2Health News:Experimental Leukemia Drug Proves a Slam Dunk 2Health News:Experimental Leukemia Drug Proves a Slam Dunk 3Health News:Experimental Leukemia Drug Proves a Slam Dunk 4Health News:Increased attention to women's health research has yielded gains on some important conditions, but progress lags on others 2Health News:Increased attention to women's health research has yielded gains on some important conditions, but progress lags on others 3Health News:David Cheresh receives top award for cancer metastasis research 2Health News:New TB vaccine enters clinical testing 2
... developed the world's first 8-channel ... completely AC powered in 1951. ... a number of standard setting ... systems, such as a Windows ...
... you're getting an ambulatory and a clinical EEG ... Mobee O2 can be used for ambulatory EEG ... or in-lab sleep studies. And both feature 32 ... placement. The Mobee O2 includes the additional enhancement ...
... The VISULAS 690s is the ... the instrument of choice for ... clinical trials, Carl Zeiss has ... in laser manufacturing to create ...
... Humphrey Lens Analyzers Model 350 and ... most comprehensive lensometry for your practice. ... Analyzer (LA) gives fast and accurate ... lenses, prism lenses, contact lenses, polycarbonate ...
Medicine Products: